| Announce Date | 11/07/2025 |
| EPS Normalized Actual | $-0.1 (Miss by $-0.12) |
| EPS GAAP Actual | $-0.1 (Miss by $-0.12) |
| Revenue Actual | $0.37075B |
| Revenue Surprise | Beat by $370.75M |
| Announce Date | 03/28/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.1 |
| EPS GAAP Estimate | $-0.1 |
| Revenue Estimate | $0.3054B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | -0.13701 | -65.62 | -0.2009 | -0.07312 | 2 |
| Dec 2026 | -0.27 | -33.3 | -0.36664 | -0.17336 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.1 | -0.12 | 0.37075B | 10.08% | 15.95M |
| FQ2 2025 (Jun 2025) | 0.13 | 0.13 | 0.329804B | 7.48% | 329.8M |
| FQ1 2025 (Mar 2025) | 0.04 | 0.04 | 0.282864B | 100% | 282.86M |
| FQ4 2024 (Dec 2024) | 0.22 | 0.22 | 0.305555B | 100% | 305.56M |
| FQ3 2024 (Sep 2024) | 0.19 | 0.19 | 0.333368B | 100% | 333.37M |
| FQ2 2024 (Jun 2024) | -0.17 | -0.17 | 0.305146B | 100% | 305.15M |
| FQ3 2021 (Sep 2021) | -0.41 | -0.41 | 0.179559B | 100% | 179.56M |
| FQ4 2021 (Dec 2021) | -0.21 | -0.21 | 0.184515B | 100% | 184.52M |
FQ4 Announce Date
03/28/2026 (Pre-Market)
Consensus EPS Estimates
-0.1
Consensus Revenue Estimates
0.3054B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | -0.01 | -- | -0.01 | -0.01 | 1 |
| FQ3 2026 (Sep 2026) | 0.04 | 350 | 0.04 | 0.04 | 1 |
| FQ2 2026 (Jun 2026) | -0.03 | 533.33 | -0.03 | -0.03 | 1 |
| FQ1 2026 (Mar 2026) | -0.1 | 140 | -0.1 | -0.1 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.37B | -- | 0.37B | 0.37B | 1 |
| FQ3 2026 (Sep 2026) | 0.39B | 4.5 | 0.39B | 0.39B | 1 |
| FQ2 2026 (Jun 2026) | 0.36B | 7.72 | 0.36B | 0.36B | 1 |
| FQ1 2026 (Mar 2026) | 0.31B | 7.38 | 0.31B | 0.31B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.02 | -0.1 | -0.12 | 120% |
| FQ2 2025 (Jun 2025) | 0.13 | 0.13 | 100% | |
| FQ1 2025 (Mar 2025) | 0.04 | 0.04 | 100% | |
| FQ4 2024 (Dec 2024) | 0.22 | 0.22 | 100% | |
| FQ3 2024 (Sep 2024) | 0.19 | 0.19 | 100% | |
| FQ2 2024 (Jun 2024) | -0.17 | -0.17 | 100% | |
| FQ3 2021 (Sep 2021) | -0.41 | -0.41 | 100% | |
| FQ4 2021 (Dec 2021) | -0.21 | -0.21 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.35B | $0.37B | $15.95M | 4.3% |
| FQ2 2025 (Jun 2025) | $0B | $0.33B | $329.8M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.28B | $282.86M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.31B | $305.56M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.33B | $333.37M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.31B | $305.15M | 100% |
| FQ3 2021 (Sep 2021) | $0B | $0.18B | $179.56M | 100% |
| FQ4 2021 (Dec 2021) | $0B | $0.18B | $184.52M | 100% |